Huaier Granule in Treating Women With Triple Negative Breast Cancer

Inclusion Criteria: * Age: ≥ 18 and ≤ 75 years, female; * Triple negative breast cancer has been surgically removed; * The triple negative breast cancer has been confirmed by pathological examination and Immunohistochemistry (IHC); * Not receiving any preoperative anticancer drugs; * The liver and kidney function satisfies the following conditions within 3 days after surgery (excluding day 3): aspartate aminotransferase (AST), glutamic-oxalacetic transaminase (ALT) \< 2 upper limit of normal (ULN), total bilirubin ≤ 1.5 ULN, serum creatinine \< 1.5 ULN; * Other laboratory tests meet the following requirements within 3 days after surgery (excluding day 3): Hb ≥ 90g/l, platelet count ≥ 100×109/L, absolute neutrophil count \> 1.5×109/L; * The expected survival time ≥ 6 months; * The subjects volunteer to sign the informed consent. Exclusion Criteria: * Patients with stage IV breast cancer; * Triple negative breast cancer was not surgically removed; * Non-triple negative breast cancer patients confirmed by pathological examination and Immunohistochemistry (IHC); * Pregnant or lactating women; * Those with active bleeding due to various reasons; * Those with HIV infection or AIDS-associated diseases; * Those with severe acute and chronic diseases; * Those with severe diabetes; * Those with serious infectious diseases; * Those who can not take drugs by oral route; * Drug abusers or those with psychological or mental diseases that may interfere with study compliance; * Conditions that are considered not suitable for this study investigators